Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation

Cancer Cell

Volumn 27, Issue 1, 2015, Pages 27-40

  Rutkowski, Melanie R ^a   Stephen, Tom L ^a   Svoronos, Nikolaos ^a   Allegrezza, Michael J ^a   Tesone, Amelia J ^a   Perales Puchalt, Alfredo ^a   Brencicova, Eva ^a   Escovar Fadul, Ximena ^a   Nguyen, Jenny M ^a   Cadungog, Mark G ^b   Zhang, Rugang ^a   Salatino, Mariana ^c   Tchou, Julia ^c,d,e   Rabinovich, Gabriel A ^f   Conejo Garcia, Jose R ^a  

^a WISTAR INSTITUTE   (United States)

^b HELEN F GRAHAM CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GALECTIN 1; INTERLEUKIN 17; INTERLEUKIN 6; K RAS PROTEIN; PROTEIN P53; TOLL LIKE RECEPTOR 5; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; COMMENSAL; CONTROLLED STUDY; GAMMA DELTA T LYMPHOCYTE; GENE EXPRESSION; GENETIC POLYMORPHISM; GRANULOCYTE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MICROFLORA; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; OUTCOME ASSESSMENT; OVARY CANCER; PRIORITY JOURNAL; SARCOMA; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR PROMOTION; UPREGULATION; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE; TUMOR CELL LINE;

MUS;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROBIOTA; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 5;

EID: 84922202505     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2014.11.009     Document Type: Article

References (26)

1. Abt, M.C., Osborne, L.C., Monticelli, L.A., Doering, T.A., Alenghat, T., Sonnenberg, G.F., Paley, M.A., Antenus, M., Williams, K.L., Erikson, J., et al. (2012). Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37, 158-170.
2. Casanova, J.L., Abel, L., and Quintana-Murci, L. (2011). Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29, 447-491.
3. Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y., and Weiser, J.N. (2010). Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16, 228-231.
4. Conejo-Garcia, J.R., Benencia, F., Courreges, M.C., Kang, E., Mohamed-Hadley, A., Buckanovich, R.J., Holtz, D.O., Jenkins, A., Na, H., Zhang, L., et al. (2004). Tumor-infiltrating dendritic cell precursors recruited by a betadefensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10, 950-958.
5. Cubillos-Ruiz, J.R., Engle, X., Scarlett, U.K., Martinez, D., Barber, A., Elgueta, R., Wang, L., Nesbeth, Y., Durant, Y., Gewirtz, A.T., et al. (2009). Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J. Clin. Invest. 119, 2231-2244.
6. Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Méndez-Huergo, S.P., Stupirski, J.C., Mazal, D., Osinaga, E., Toscano, M.A., et al. (2013). Targeting galectin-1 overcomes breast cancerassociated immunosuppression and prevents metastatic disease. Cancer Res. 73, 1107-1117.
7. Gewirtz, A.T., Vijay-Kumar, M., Brant, S.R., Duerr, R.H., Nicolae, D.L., and Cho, J.H. (2006). Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1157-G1163.
8. Hawn, T.R., Verbon, A., Lettinga, K.D., Zhao, L.P., Li, S.S., Laws, R.J., Skerrett, S.J., Beutler, B., Schroeder, L., Nachman, A., et al. (2003). A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198, 1563-1572.
9. Hawn, T.R., Scholes, D., Li, S.S., Wang, H., Yang, Y., Roberts, P.L., Stapleton, A.E., Janer, M., Aderem, A., Stamm, W.E., et al. (2009). Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS ONE 4, e5990.
10. Hugot, J.P., Zaccaria, I., Cavanaugh, J., Yang, H., Vermeire, S., Lappalainen, M., Schreiber, S., Annese, V., Jewell, D.P., Fowler, E.V., et al.; IBD International Genetics Consortium (2007). Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am. J. Gastroenterol. 102, 1259-1267.
11. Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A., Molina, D.A., Salcedo, R., Back, T., Cramer, S., et al. (2013). Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967-970.
12. Jackson, E.L., Willis, N., Mercer, K., Bronson, R.T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D.A. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248.
13. Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., and Berns, A. (2001). Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29, 418-425.
14. Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T.H., et al. (2009). Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114, 1141-1149.
15. Mazmanian, S.K., Round, J.L., and Kasper, D.L. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625.
16. Misch, E., and Hawn, T. (2008). Toll-like receptor polymorphisms and susceptibility to human disease. Clinical science (London, England: 1979) 114, 347-360.
17. Peng, G., Wang, H.Y., Peng, W., Kiniwa, Y., Seo, K.H., and Wang, R.F. (2007). Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 27, 334-348.
18. Rabinovich, G.A., and Croci, D.O. (2012). Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 36, 322-335.
19. Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O.L., and Rabinovich, G.A. (2004). Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumorimmune privilege. Cancer Cell 5, 241-251.
20. Rutkowski, M.R., Allegrezza, M.J., Svoronos, N., Tesone, A.J., Stephen, T.L., Perales-Puchalt, A., Nguyen, J., Zhang, P.J., Fiering, S.N., Tchou, J., and Conejo-Garcia, J.R. (2014). Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancer. J. Vis. Exp. 26.
21. Ryzhov, S., Novitskiy, S.V., Goldstein, A.E., Biktasova, A., Blackburn, M.R., Biaggioni, I., Dikov, M.M., and Feoktistov, I. (2011). Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells. J. Immunol. 187, 6120-6129.
22. Sampath, V., Garland, J.S., Le, M., Patel, A.L., Konduri, G.G., Cohen, J.D., Simpson, P.M., and Hines, R.N. (2012). A TLR5 (g.1174C > T) variant that encodes a stop codon (R392X) is associated with bronchopulmonary dysplasia. Pediatr. Pulmonol. 47, 460-468.
23. Scarlett, U.K., Rutkowski, M.R., Rauwerdink, A.M., Fields, J., Escovar-Fadul, X., Baird, J., Cubillos-Ruiz, J.R., Jacobs, A.C., Gonzalez, J.L., Weaver, J., et al. (2012). Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J. Exp. Med. 209, 495-506.
24. Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D., Zwirner, N.W., Poirier, F., Riley, E.M., Baum, L.G., and Rabinovich, G.A. (2007). Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8, 825-834.
25. Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D.P., Pfirschke, C., Engblom, C., Pittet, M.L., et al. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976.
26. Wang, L., Yi, T., Kortylewski, M., Pardoll, D.M., Zeng, D., and Yu, H. (2009). IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J. Exp. Med. 206, 1457-1464.